Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 3/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.63 |
| ▸ | TYR | P14679 | 3/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | SLC5A2 | P31639 | 5/20 | 0.59 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7181752 | 1.00 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL3664789 | 1.00 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL8657750 | 1.00 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL2923796 | 1.00 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL1706261 | 1.00 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL2917655 | 0.98 | SLC28A3 (0.68) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL13324378 | 0.98 | SLC28A3 (0.68) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL2927767 | 0.98 | SLC28A3 (0.68) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL3662700 | 0.98 | SLC28A3 (0.68) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL12610461 | 0.89 | SLC28A3 (0.71) | SLC28A3HIF1ATYRATMSLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270104-A1 | USE OF ERYTHRITOL COMPOSITIONS AS MAMMAL-SAFE INSECTICIDES | UNIV DREXEL (US) | 2023-08-31 | — | — | US | claimed |
| US-20220061319-A1 | Use of Erythritol Compositions As Mammal-Safe Insecticides | NATIONAL SCIENCE FOUNDATION | 2022-03-03 | — | — | US | claimed |
| JP-4005218-A | — | — | None | — | — | JP | disclosed |
| US-20230270104-A1 | USE OF ERYTHRITOL COMPOSITIONS AS MAMMAL-SAFE INSECTICIDES | UNIV DREXEL (US) | 2023-08-31 | — | — | US | disclosed |
| US-20220061319-A1 | Use of Erythritol Compositions As Mammal-Safe Insecticides | NATIONAL SCIENCE FOUNDATION | 2022-03-03 | — | — | US | disclosed |
| EP-2611903-B1 | USE OF A BETA-GLUCOSIDASE ACTIVATOR FOR DETECTING AND/OR IDENTIFYING C. DIFFICILE | BIOMERIEUX SA (FR) | 2016-10-05 | — | — | EP | disclosed |
| CN-101970682-B | Method for detecting and/or identifying clostridium difficile | BIOMERIEUX SA | 2015-05-13 | — | — | CN | disclosed |
| EP-2611903-A1 | USE OF A BETA-GLUCOSIDASE ACTIVATOR FOR DETECTING AND/OR IDENTIFYING C. DIFFICILE | Biomérieux (FR) | 2013-07-10 | — | — | EP | disclosed |
| EP-2235202-B1 | METHOD FOR DETECTING AND/OR IDENTIFYING CLOSTRIDIUM DIFFICILE | BIOMERIEUX SA (FR) | 2013-06-19 | — | — | EP | disclosed |
| US-20130137126-A1 | USE OF A BETA-GLUCOSIDASE ACTIVATOR FOR THE DETECTION AND/OR IDENTIFICATION OF C. DIFFICILE | BIOMERIEUX (FR) | 2013-05-30 | — | — | US | disclosed |
| US-8404460-B2 | Method for detecting and/or identifying Clostridium difficile | BIOMERIEUX (FR) | 2013-03-26 | — | — | US | disclosed |
| US-6964124-B2 | Devices and methods for eliminating termite colonies | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2005-11-15 | — | — | US | disclosed |
| US-20040170661-A1 | Devices and methods for eliminating termite colonies | THE PROCTER & GAMBLE COMPANY | 2004-09-02 | — | — | US | disclosed |
| US-6716421-B2 | BAIT MATRICES AND BAIT STATIONS FOR ELIMINATING TERMITE COLONIES AND | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2004-04-06 | — | — | US | disclosed |
| US-20030124164-A1 | Devices and methods for eliminating termite colonies | THE PROCTER & GAMBLE COMPANY | 2003-07-03 | — | — | US | disclosed |
| US-20030124166-A1 | Termiticidal bait matrix can be used in a bait station installed in the ground. | FLORIDA RESEARCH FOUNDATION, INC., THE UNIVERSITY OF | 2003-07-03 | — | — | US | disclosed |
| US-20030017187-A1 | Devices and methods for eliminating termite colonies | THE PROCTER & GAMBLE COMPANY | 2003-01-23 | — | — | US | disclosed |
| US-5766267-A | USING FIBER REACTIVE DYES | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-06-16 | — | — | US | disclosed |
| EP-0745719-A2 | Use of carbohydrate compounds as auxiliary agents in the dyeing or printing of fibrous materials | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-12-04 | — | — | EP | disclosed |
| JP-H045218-A | HAIR COSMETIC | POLA CHEM IND INC | 1992-01-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030124166-A1 | Termiticidal bait matrix can be used in a bait station installed in the ground. | CA3, ADAMTS12, MMP7 | SLC28A3 4199/4885HIF1A 4693/4885TYR 2194/4885 |
| US-20040170661-A1 | Devices and methods for eliminating termite colonies | CA3, MLN, TRHDE | SLC28A3 3946/4885HIF1A 4428/4885TYR 865/4885 |
| US-20030124164-A1 | Devices and methods for eliminating termite colonies | CA3, MLN, TRHDE | SLC28A3 3946/4885HIF1A 4428/4885TYR 865/4885 |
| US-20030017187-A1 | Devices and methods for eliminating termite colonies | CA3, PHB1, COX6C | SLC28A3 4039/4885HIF1A 3979/4885TYR 1454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.